This new commentary explores where psychedelic mental health treatments might be heading and what needs to happen next.

Pop star Lorde said in a recent interview with Stephen Colbert that the psychedelic drug MDMA, also known as molly or ecstasy ...

A mid-stage trial of BPL‑003 nasal spray shows promising results for treatment-resistant depression, igniting biotech ...

Trip sitter is a phrase that traditionally refers to a sober person tasked with monitoring someone who's under the influence ...

Busting stigma is no small task, especially when it involves convincing the public that a psychedelic drug might one day be ...

The head of the U.S. Department of Veterans Affairs (VA) says he’s “particularly proud” of the administration’s work to ...

Bipartisan congressional lawmakers have teamed up on another psychedelics amendment to appropriations legislation—this time ...

Some planners and therapists are calling for more research into potential applications for methods already being used to ...

More than three years after a bubble in psychedelic drug stocks burst there are signs that the bad trip for investors is over ...

Researchers at Baylor College of Medicine found that psilocybin improved cell longevity and boosted survival in aged mice.

With more and more data showing the efficacy of psychedelic treatments for PTSD and other mental health conditions, there has ...

A psychedelic nasal spray requiring a much shorter period of clinical supervision has shown promise against ...